ArticleProbiotics and antimicrobial proteins2026
Artificial Intelligence and Protein Design: A retrospective study on 20-year emerging trends and core research areas from bibliometric perspectives.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Protein design has numerous applications in synthetic biology, drug discovery, and bioengineering. Recently, there has been a revolution in this field due to the emergence of artificial intelligence. At the forefront are deep learning models (DLMs). The impact of these models on the design pipeline is so transformative that it leads to radical advances in prediction accuracy, functional enrichment, and de novo synthesis of proteins. We performed bibliometric analysis on a Web of Science data-set (2006-2025) obtained through a targeted keyword search. Our analysis method orchestrated the use of standard tools such as CiteSpace and VOSviewer for co-citation, keyword co-occurrence, and burst detection, while we used custom python scripts to generate more nuanced plots for collaboration networks and intellectual overlap. Based on the bibliometric analysis, we observe a sudden jump in publication counts after the year 2018. This period also coincides with the publication of many methodological breakthroughs such as AlphaFold2 and RoseTTAFold. The analysis revealed three major intellectual clusters focused around protein structure prediction, directed evolution, and de novo design of proteins. DLMs play a major role in the publication impact of generating functional protein sequences, with frameworks such as ProteinMPNN having a notable citation footprint. Although China and the United States dominated in raw publication volume, citation impact told a different story-Switzerland ranked second in per-publication influence, suggesting that research programs combining computational design with systematic experimental validation tend to generate disproportionate scholarly impact. International collaborative efforts were notable after 2020. Citation and co-citation analysis highlighted works that have formed the bedrock of this field. Notable mentions include seminal works on AlphaFold2, ProteinMPNN, and RFdiffusion. Protein design stands at the center of an AI revolution that has drawn database mining, computational generation, and experimental validation into an increasingly rapid and interconnected engineering loop. Yet sustaining this momentum requires confronting limitations that the field's most cited literature has largely left unspoken: models trained on stable, crystallizable structures struggle to generalize beyond their training distributions, static predictions remain blind to the conformational dynamics governing allostery and catalysis, and in silico confidence scores have repeatedly proven poor predictors of wet-lab outcomes. Closing this gap will demand not incremental refinement but the sustained, bidirectional coupling of high-throughput experimental feedback with iterative design-test-learn cycles, supported by next-generation models that natively represent PTMs, cellular context, and conformational ensembles-a convergence that holds genuine promise for translating the field's computational ambitions into reliable therapeutic and synthetic biology outcomes.
Indexed as
Identifiers
42470596What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.